Performance characteristics of a quantitative, standardised varicella zoster IgG time resolved fluorescence immunoassay (VZV TRFIA) for measuring antibody following natural infection

Journal of Virological Methods

Volumn 157, Issue 1, 2009, Pages 90-92

  Chris Maple, P A ^a   Gray, Jim ^a   Brown, Kevin ^a   Brown, David ^a  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

Merck glycoprotein EIA; Standardised cut offs for susceptibility and protection; VZV time resolved fluorescence immunoassay

Indexed keywords

GLYCOPROTEIN E1; HERPES ZOSTER IMMUNOGLOBULIN;

ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; IMMUNE RESPONSE; IMMUNOASSAY; INTERMETHOD COMPARISON; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; STANDARDIZATION; TIME RESOLVED FLUORESCENCE IMMUNOASSAY; VARICELLA ZOSTER VIRUS;

ANTIBODIES, VIRAL; CHICKENPOX; FEMALE; FLUORESCENCE; HERPESVIRUS 3, HUMAN; HUMANS; IMMUNOASSAY; IMMUNOGLOBULIN G; PREGNANCY; SENSITIVITY AND SPECIFICITY;

HUMAN HERPESVIRUS 3;

EID: 60849083795     PISSN: 01660934     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jviromet.2008.12.007     Document Type: Article

References (19)

1. Arvin A.M. Varicella vaccine-the first six years. N. Engl. J. Med. 344 (2001) 1007-1009
2. Cohen B.J., Audet S., Andrews N., and Beeler J. Plaque reduction neutralization test for measles antibodies: description of a standardised laboratory method for use in immunogenicity studies of aerosol vaccination. Vaccine 26 (2007) 59-66
3. Grandien M., Appelgren P., Espmark A., and Hanngren K. Determination of Varicella immunity by the indirect immunofluorescence test in urgent clinical situations. Scand. J. Infect. Dis. 8 (1976) 65-69
4. Grose C., Edmond B.J., and Brunell P.A. Complement enhanced neutralizing antibody response to Varicella-Zoster virus. J. Infect. Dis. 139 (1979) 432-437
5. Li S., Chan I.S.F., Matthews H., Heyse J.F., Chan C.Y., Kuter B.J., Kaplan K.M., Vessey S.J.R., and Sadoff J.C. Inverse relationship between six week post vaccination varicella antibody response to vaccine and likelihood of long term breakthrough infection. Pediatr. Infect. Dis. J. 21 (2002) 337-342
6. Maple P.A., Efstratiou A., George R.C., Andrews N.J., and Sesardic D. Diphtheria immunity in UK blood donors. Lancet 345 (1995) 963-965
7. Maple P.A.C., Jones C.S., Wall E.C., Vyse A., Edmunds W.J., Andrews N.J., and Miller E. Immunity to diphtheria and tetanus in England and Wales. Vaccine 19 (2001) 167-173
8. Maple P.A.C., and Jones C.S. Time-resolved fluorometric immunoassay for rubella antibody-a useful method for serosurveillance studies. Vaccine 20 (2002) 1378-1382
9. Maple P.A.C., Gray J., Breuer J., Kafatos G., Parker S., and Brown D. Performance of a time-resolved fluorescence immunoassay for measuring Varicella-Zoster virus immunoglobulin G levels in adults and comparison with commercial enzyme immunoassays and Merck glycoprotein enzyme immunoassay. Clin. Vaccine Immunol. 13 (2006) 214-218
10. Marin M., Guris D., Chaves S.S., Schmid S., and Sew J.F. Prevention of Varicella. Recommendations of the Advisory Committee on Immunization Practices. MMWR 56 RR04 (2007) 1-40
11. Ndumbe P.M., Cradock-Watson J., and Levinsky R.J. Natural and artificial immunity to Varicella Zoster virus. J. Med. Virol. 25 (1988) 171-178
12. Provost P.J., Krah D.L., Kuter B.J., Morton D.H., Schofield T.L., Wasmuth E.H., White C.J., Miller W.J., and Ellis R.W. Antibody assays suitable for assessing immune responses to live varicella vaccine. Vaccine 9 (1991) 111-116
13. Robert Koch-Institut. Mitteilung der Standigen impfkommission (STIKO) am Robert Koch-Institut. Fragen und Antworten zu verschiedenen Impfungen. Epidemiol. Bull. 8 (2001) 58
14. Sauerbrei A., Farber I., Brandstadt A., Schacke M., and Wutzler P. Immunofluorescence test for sensitive detection of varicella-zoster virus-specific IgG: an alternative to fluorescent antibody to membrane antigen test. J. Virol. Methods 119 (2004) 25-30
15. Steinberg S.P., and Gershon A.A. Measurement of antibodies to Varicella-Zoster virus by using a latex agglutination test. J. Clin. Microbiol. 29 (1991) 1527-1529
16. Tischer A., Andrews N., Kafatos G., Nardone A., Berbers G., Davidkin I., Aboudy Y., Backhouse J., Barbara C., Bartha K., Bruckova B., Duks A., Griskevicius A., Hesketh L., Johansen K., Jones L., Kuersteiner O., Lupulescu E., Mihneva Z., Mrazova M., De Ory F., Prosenc K., Schneider F., Tsakris A., Smelhausova M., Vranckz R., Zarvou M., and Miller E. Standardization of measles, mumps and rubella assays to enable comparisons of seroprevalence data across 21 European countries and Australia. Epidemiol. Infect. 135 (2007) 787-797
17. Wasmuth E.H., and Miller W.J. Sensitive enzyme-linked immunosorbent assay for antibody to Varicella-Zoster virus using purified VZV glycoprotein antigen. J. Med. Virol. 32 (1990) 189-193
18. Williams V., Gershon A., and Brunell P.A. Serologic response to Varicella-Zoster membrane antigens measured by indirect fluorescence. J. Infect. Dis. 130 (1974) 669-672
19. Zaia J.A., and Oxman M.N. Antibody to Varicella-Zoster virus-induced membrane antigen: immunofluorescence assay using monodisperse glutaraldehyde fixed target cells. J. Infect. Dis. 136 (1977) 519-530